Lv2
170 积分 2024-01-22 加入
Identification, structure, and agonist design of an androgen membrane receptor
1天前
待确认
Synthetic Lethality Exploitation by an Anti–Trop-2-SN-38 Antibody–Drug Conjugate, IMMU-132, Plus PARP Inhibitors in BRCA1/2–wild-type Triple-Negative Breast Cancer
5天前
已完结
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications
8天前
已完结
BTK inhibitors: past, present, and future
9天前
已完结
A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors
12天前
已完结
An Antibody‐Drug Conjugate for Multiple Myeloma Prepared by Multi‐Arm Linkers
14天前
已完结
Abstract 2700: ORM-6151: A first-in-class CD33-antibody enabled GSPT1 degrader for AML
14天前
已关闭
Synthesis and in Vitro Evaluation of a Peptidomimetic Inhibitor Targeting the Src Homology 2 (SH2) Domain of STAT6
16天前
已完结
Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide
22天前
已完结
Muscle-derived myostatin is a major endocrine driver of follicle-stimulating hormone synthesis
23天前
已完结
皖公网安备34019202002308
